» Articles » PMID: 29299831

Sarcoidosis: a Review for the Internist

Overview
Publisher Springer
Date 2018 Jan 5
PMID 29299831
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcoidosis is a systemic granulomatous lung disease of unknown origin affecting people of any age, mainly young adults. The disease is extremely heterogeneous with an unpredictable clinical course. Different phenotypes have been identified: an acute syndrome can be distinguished from subacute and chronic variants. About 20% of patients are chronically progressive and may develop lung fibrosis. Sarcoidosis usually involves the lungs and thoracic lymph nodes, although the skin, eyes, bones, liver, spleen, heart, upper respiratory tract and nervous system can also be affected. No reliable indicators of clinical outcome are available, and there is no single serological biomarker with demonstrated unequivocal diagnostic and prognostic value. Diagnosis requires histological confirmation although a presumptive diagnosis may be acceptable in special conditions. This review examines the diagnostic approach to sarcoidosis involving a multidisciplinary team of specialists in which the internist has the task of identifying all pulmonary and extrapulmonary localizations of the disease and of managing complications and comorbidities.

Citing Articles

A review of sarcoidosis etiology, diagnosis and treatment.

Waly Y, Sharafeldin A, Akhtar M, Chilmeran Z, Fredericks S Front Med (Lausanne). 2025; 12:1558049.

PMID: 40078389 PMC: 11897256. DOI: 10.3389/fmed.2025.1558049.


Shaping Rare Granulomatous Diseases in the Lab: How New Models Are Changing the Game.

Ceccato J, Gualtiero G, Piazza M, Carraro S, Buso H, Felice C Cells. 2025; 14(4).

PMID: 39996765 PMC: 11853845. DOI: 10.3390/cells14040293.


New Mediastinal and Hilar Lymphadenopathy After Adjuvant Pembrolizumab in a Patient With Stage III Clear Cell Renal Cell Carcinoma.

Lee M, Styrvoky K, Cai Q, Taboada P, Hoyer R, Gray Z Cureus. 2025; 16(12):e76514.

PMID: 39872587 PMC: 11771458. DOI: 10.7759/cureus.76514.


Neurosarcoidosis Presenting With Diffuse Multinodular Pachymeningeal Enhancement in the Cervicothoracic Spine: A Case Report and Review of the Literature.

Zheng A, Chiu R, Secola S, Payne R Cureus. 2024; 16(11):e73241.

PMID: 39650894 PMC: 11625014. DOI: 10.7759/cureus.73241.


Chronic Sarcoidosis: Diagnostic Difficulties and Search for New Criteria of Inflammatory Activity (A Case Report and Literature Review).

Starshinova A, Berg E, Rubinstein A, Kulpina A, Kudryavtsev I, Kudlay D J Clin Med. 2024; 13(22).

PMID: 39598118 PMC: 11594891. DOI: 10.3390/jcm13226974.


References
1.
Levitt D, Levitt M . Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin Exp Gastroenterol. 2017; 10:147-168. PMC: 5522668. DOI: 10.2147/CEG.S136803. View

2.
Baughman R, Papanikolaou I . Current concepts regarding calcium metabolism and bone health in sarcoidosis. Curr Opin Pulm Med. 2017; 23(5):476-481. DOI: 10.1097/MCP.0000000000000400. View

3.
Hebel R, Dubaniewicz-Wybieralska M, Dubaniewicz A . Overview of neurosarcoidosis: recent advances. J Neurol. 2014; 262(2):258-67. PMC: 4330460. DOI: 10.1007/s00415-014-7482-9. View

4.
Kingah P, Alam M, Chugh K, Kamholz J, Samavati L . Role of Pulmonary Evaluation in Diagnosis of Neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2016; 33(3):209-215. View

5.
Ivanisevic J, Kotur-Stevuljevic J, Stefanovic A, Spasic S, Vucinic Mihailovic V, Videnovic Ivanov J . Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients. Eur J Clin Invest. 2016; 46(5):418-24. DOI: 10.1111/eci.12610. View